Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Non-Small-Cell Lung
In brief
This study was designed to evaluate the role of canakinumab in combination with docetaxel in subjects with advanced non-small cell lung cancer (NSCLC) previously treated with PD-(L)1 inhibitors and platinum-based chemotherapy.
Key facts
- Study ID
- NCT03626545
- Run by
- Novartis Pharmaceuticals
- People needed
- 245
- Starts
- 2019-01-23
- Expected to finish
- 2021-12-20
- Last updated by the study team
- 2023-08-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Saint Luke's Hospital/Marion Bloch Neuroscience Institute Dept of Regulatory — Kansas City, Missouri, United States
- Montefiore Medical Center Albert Einstein College of Med — The Bronx, New York, United States
- University of Cincinnati Cancer Institute — Cincinnati, Ohio, United States
- MD Anderson — Houston, Texas, United States
- Huntsman Cancer Institute Univ of Utah . — Salt Lake City, Utah, United States
- Novartis Investigative Site — Berazategui, Buenos Aires, Argentina
- Novartis Investigative Site — CABA, Buenos Aires, Argentina
- Novartis Investigative Site — Mar del Plata, Buenos Aires, Argentina
- Novartis Investigative Site — La Rioja, Argentina
- Novartis Investigative Site — Santiago del Estero, Argentina
- Novartis Investigative Site — Greenslopes, Queensland, Australia
- Novartis Investigative Site — Shepparton, Victoria, Australia
- Novartis Investigative Site — Sint-Niklaas, Oost Vlaanderen, Belgium
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Charleroi, Belgium
- Novartis Investigative Site — Ghent, Belgium
- Novartis Investigative Site — Roeselare, Belgium
- Novartis Investigative Site — Salvador, Estado de Bahia, Brazil
- Novartis Investigative Site — Porto Alegre, Rio Grande do Sul, Brazil
- Novartis Investigative Site — Itajaí, Santa Catarina, Brazil
- Novartis Investigative Site — Vancouver, British Columbia, Canada
- Novartis Investigative Site — Montreal, Quebec, Canada
- Novartis Investigative Site — Santiago, Chile
- Novartis Investigative Site — Chengdu, Sichuan, China
- Emory Winship Cancer Institute — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.